These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22410457)

  • 1. Personalized management of patients with solid cancers: moving from patient characteristics to tumor biology.
    Awada A; Vandone AM; Aftimos P
    Curr Opin Oncol; 2012 May; 24(3):297-304. PubMed ID: 22410457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of molecular findings to the diagnosis and management of breast disease: recent advances and challenges.
    Simpson PT; Vargas AC; Al-Ejeh F; Khanna KK; Chenevix-Trench G; Lakhani SR
    Hum Pathol; 2011 Feb; 42(2):153-65. PubMed ID: 21106225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Developments in cancer care with innovative genomics. 2008 report of the National Cancer Consortium].
    Tímár J; Kásler M; Heringh A; Soós M; Mathiász D; Romány A; Józsa A; Szilák L; Forrai T; Patthy L; Kovács G
    Magy Onkol; 2009 Dec; 53(4):321-34. PubMed ID: 20071304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic strategies for personalized cancer therapy.
    Garman KS; Nevins JR; Potti A
    Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R226-32. PubMed ID: 17911165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic signatures of cancer: basis for individualized risk assessment, selective staging and therapy.
    Baehner FL; Lee M; Demeure MJ; Bussey KJ; Kiefer JA; Barrett MT
    J Surg Oncol; 2011 May; 103(6):563-73. PubMed ID: 21480251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
    Correa Geyer F; Reis-Filho JS
    Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.
    Glinsky GV
    J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized treatment of early-stage breast cancer: present concepts and future directions.
    Harbeck N; Salem M; Nitz U; Gluz O; Liedtke C
    Cancer Treat Rev; 2010 Dec; 36(8):584-94. PubMed ID: 20554119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarrays in gastrointestinal cancer: is personalized prediction of response to chemotherapy at hand?
    Jensen EH; McLoughlin JM; Yeatman TJ
    Curr Opin Oncol; 2006 Jul; 18(4):374-80. PubMed ID: 16721134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal stromal tumors: a contemporary review.
    Parfitt JR; Streutker CJ; Riddell RH; Driman DK
    Pathol Res Pract; 2006; 202(12):837-47. PubMed ID: 17064855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New developments in gastrointestinal stromal tumor.
    Trent JC; Benjamin RS
    Curr Opin Oncol; 2006 Jul; 18(4):386-95. PubMed ID: 16721136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gastrointestinal stromal tumors (GIST)--a paradigm of successful targeted therapy of solid tumors].
    Belev B; Vrbanec D; Kralik M; Plestina S; Petricević B; Sirotković-Skerlev M
    Acta Med Croatica; 2006 Dec; 60(5):471-5. PubMed ID: 17217104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiles as an additional tool to conventional predictive factors to assist in management of early endocrine responsive breast cancer.
    Chow LW
    Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S13-7. PubMed ID: 20374025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathways to personalized medicine for breast and prostate cancers: emerging diagnostic methods and prognostic biomarkers.
    Watson AP; Egland KA
    S D Med; 2010 Jul; 63(7):247-53. PubMed ID: 20666024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal stromal tumor surgery and adjuvant therapy.
    Grignol VP; Termuhlen PM
    Surg Clin North Am; 2011 Oct; 91(5):1079-87. PubMed ID: 21889030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular prediction of the therapeutic response to neoadjuvant chemotherapy in breast cancer.
    Nagasaki K; Miki Y
    Breast Cancer; 2008; 15(2):117-20. PubMed ID: 18274834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple-negative breast cancer.
    Stockmans G; Deraedt K; Wildiers H; Moerman P; Paridaens R
    Curr Opin Oncol; 2008 Nov; 20(6):614-20. PubMed ID: 18841042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The paradigm of personalized therapy in oncology.
    Gasparini G; Longo R
    Expert Opin Ther Targets; 2012 Mar; 16 Suppl 1():S7-16. PubMed ID: 22073968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal stromal tumor presenting as a rectovaginal mass. Clinicopathologic and molecular-genetic characterization of a rare tumor with a literature review.
    Pelz AF; Agaimy A; Daniels M; Evert M; Schulz HU; Lüders P; Müller G; Lasota J; Röpke A; Wieacker P; Miettinen M; Schneider-Stock R
    Hum Pathol; 2011 Apr; 42(4):586-93. PubMed ID: 21237497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.